Clinical Trials

Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD)

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

Stacking Exercises Aid the Decline in FVC and Sick Time

Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)

Telerehabilitation in Duchenne Muscular Dystrophy

A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice

Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA

The U.K. NorthStar Clinical Network

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

Estimation of Non-Reimbursable Costs for Patients With Duchenne Muscular Dystrophy in France

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74

A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects